Euan Thomson

Investor

Frontier Health Technologies (focus area at 1955 Capital) at 1955 Capital

About

Euan Thomson focuses on frontier health technologies at 1955 Capital, with an emphasis on data-driven healthcare, clinical decision-making, and system efficiency. He has over 30 years of experience across medical devices, digital health, and healthcare systems, including prior roles as a Partner at Khosla Ventures, President and CEO of Accuray (which he led through its 2007 IPO), President and CEO of Carl Zeiss Meditec, Head of Digital Health at Samsung, Global Head of R&D at Johnson & Johnson, and CEO of AliveCor. He holds a BS, MS, and PhD in Medical Physics from the University of London.

LinkedIn ↗